TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T40016	Glucocorticoid receptor	D0G3SH	Ursodeoxycholic acid	Approved	31401	C24H40O4	392.6	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	EC50 = 298700 nM	Non binder
T40016	Glucocorticoid receptor	B6V1CT	(9R,10S,11S,13S,16R,17R)-17-(2-Bromoacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	Investigative	44294670	C22H28BrFO4	455.4	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CBr)O)C)O)F)C	EC50 = 8300000000 nM	Non binder
T40016	Glucocorticoid receptor	BG92XC	(9R,10S,11S,13S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-[2-(2-isothiocyanatoethylsulfanyl)acetyl]-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	Investigative	44294768	C25H32FNO4S2	493.7	C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CSCCN=C=S)O)C)O)F)C	EC50 = 9100000000 nM	Non binder